We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTCH icon
226
Match Group
MTCH
$8.84B
$64.5M 0.08%
1,703,990
+89,338
+6% +$3.13M
PANW icon
227
Palo Alto Networks
PANW
$264B
$64.2M 0.08%
375,926
+372,932
+12,456% +$62.8M
SWTX
228
DELISTED
SpringWorks Therapeutics
SWTX
$62.9M 0.08%
1,961,830
-371,287
-16% -$13.9M
VIK icon
229
Viking Holdings
VIK
$44.9B
$62.2M 0.08%
1,783,773
+1,436,084
+413% +$49.1M
CLF icon
230
Cleveland-Cliffs
CLF
$6.81B
$62M 0.08%
4,851,936
+3,684,968
+316% +$50M
MTZ icon
231
MasTec
MTZ
$26.7B
$61.6M 0.08%
500,491
-217,595
-30% -$23.8M
WFRD icon
232
Weatherford International
WFRD
$6.36B
$61.6M 0.08%
724,858
+112,616
+18% +$12.1M
CRL icon
233
Charles River Laboratories
CRL
$10.9B
$60.9M 0.07%
309,059
-516,846
-63% -$107M
AEO icon
234
American Eagle Outfitters
AEO
$2.85B
$60.7M 0.07%
2,710,620
+1,366,703
+102% +$28.2M
TIP icon
235
iShares TIPS Bond ETF
TIP
$14.5B
$59.6M 0.07%
539,370
-22,200
-4% -$2.41M
FISV
236
Fiserv Inc
FISV
$27.2B
$59.5M 0.07%
331,000
+281,876
+574% +$46.5M
XLC icon
237
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$59.4M 0.07%
+656,823
New +$56.6M
RITM icon
238
Rithm Capital
RITM
$5.09B
$59.3M 0.07%
+5,222,558
New +$59.4M
CG icon
239
Carlyle Group
CG
$16.3B
$59.1M 0.07%
1,373,167
+451,408
+49% +$18.9M
MLTX icon
240
MoonLake Immunotherapeutics
MLTX
$1.59B
$58.2M 0.07%
1,154,385
+55,755
+5% +$2.61M
WHR icon
241
Whirlpool
WHR
$2.42B
$57.9M 0.07%
541,054
-178,436
-25% -$17.9M
ENTG icon
242
Entegris
ENTG
$19.7B
$57.3M 0.07%
509,436
+198,603
+64% +$23.5M
DNLI icon
243
Denali Therapeutics
DNLI
$3.67B
$57.3M 0.07%
1,967,141
-451,692
-19% -$11.2M
NTRA icon
244
Natera
NTRA
$37.5B
$57.3M 0.07%
451,046
-507,337
-53% -$58.2M
ITUB icon
245
Itaú Unibanco
ITUB
$91.3B
$57.2M 0.07%
9,741,681
+1,041,022
+12% +$5.86M
VRSK icon
246
Verisk Analytics
VRSK
$26.4B
$56.9M 0.07%
+212,425
New +$57.5M
IBM icon
247
PUT
IBM
IBM
$202B
$56.4M 0.07%
255,000
+110,000
+76% +$21.6M
INSM icon
248
Insmed
INSM
$23.2B
$56.3M 0.07%
771,211
-478,140
-38% -$35.3M
NICE icon
249
Nice
NICE
$5.29B
$56.1M 0.07%
323,245
+66,947
+26% +$11.5M
AGIO icon
250
Agios Pharmaceuticals
AGIO
$2.16B
$56.1M 0.07%
1,263,285
+129,550
+11% +$5.88M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.